Charité Research Organisation undertakes First Time in Human, Phase I and POC studies in both haematological and oncological indications. Extensive collaboration with the Charité Departments of Haematology and Oncology is complemented by cooperation with individual departments and clinics seeing patients with specific solid tumours.
This is supported by the wider Charité Comprehensive Cancer Center, ensuring that a fully inclusive approach to early development is offered. Charité KOLs, in collaboration with CRO, are thus able to address the vast majority of study requirements.
CRO’s early development efforts are supported by dedicated oncology bed capacity and access to the latest imaging and diagnostic capabilities.